Oral iptacopan monotherapy demonstrates clinically meaningful hemoglobin increases in patients with paroxysmal nocturnal hemoglobinuria with baseline hemoglobin levels 10 to <12 g/dl on anti-C5 therapy: Subgroup analysis of the appulse-pnh Phase 3b trial

Kulasekararaj A., Sicre-de-Fontbrune F., Gaya A., Weitz I., Kuter D., Araten D., ...More

67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 6 - 09 December 2025, vol.146, pp.4981-4982, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 146
  • Doi Number: 10.1182/blood-2025-4981
  • City: Florida
  • Country: United States Of America
  • Page Numbers: pp.4981-4982
  • Istanbul University Affiliated: Yes